The Board approved proposal for voluntary striking off of non- operative subsidiary Company namely Relic Pharma Limited
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Relic Technologies Ltd's Board has approved the voluntary strike-off of its non-operational subsidiary, Relic Pharma Limited. Relic Pharma contributed zero turnover and zero income to the parent, with a negligible net worth of approximately ₹1.019 lakhs (0.05% of the parent's net worth). The strike-off is expected to be completed by March 31, 2026, subject to approval from the Registrar of Companies. The subsidiary has been non-operational, which is the reason cited for its closure.
This is a routine housekeeping action with no material financial impact on Relic Technologies since the subsidiary is non-operational and contributes negligible value. Shareholders are unlikely to see any meaningful change in the company's financials or stock price as a result.